Engineered immune cells aim to calm liver scarring in first human trial
NCT ID NCT06823713
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new treatment called RTX001 for people with severe liver scarring (cirrhosis) that has led to complications. RTX001 uses the patient's own immune cells, modified in a lab to reduce inflammation and scarring. The trial will enroll 30 adults to check if the therapy is safe and can help control the disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS, DECOMPENSATED are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bristol Royal Infirmary
RECRUITINGBristol, BS2 8HW, United Kingdom
-
Glasgow Royal Infirmary
RECRUITINGGlasgow, G4 0SF, United Kingdom
-
Hospital General Universitario Gregorio Marañon
RECRUITINGMadrid, 28007, Spain
-
Hospital Universitari Vall d'Hebron
RECRUITINGBarcelona, 08035, Spain
-
Hospital Universitario La Paz
RECRUITINGMadrid, 28046, Spain
-
Hospital Universitario Ramón y Cajal
RECRUITINGMadrid, 28034, Spain
-
Hospital Universitario Reina Sofía
RECRUITINGCórdoba, 14004, Spain
-
Hospital Universitario Virgen del Rocío
RECRUITINGSeville, 41013, Spain
-
King's College Hospital
RECRUITINGLondon, SE5 9RS, United Kingdom
-
Nottingham University Hospital
RECRUITINGNottingham, NG5 1PB, United Kingdom
-
Royal Infirmary of Edinburgh
RECRUITINGEdinburgh, EH16 4SA, United Kingdom
-
Royal Liverpool University Hospital
RECRUITINGLiverpool, L7 8YE, United Kingdom
-
St George's Hospital
RECRUITINGLondon, SW17 0QT, United Kingdom
-
St Mary's Hospital
RECRUITINGLondon, W2 1NY, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smartphone app tame Alcohol-Related liver disease?
- Can a smarter scan make liver testing more reliable?
- Heart scans could flag Who's at risk after liver shunt
- A new Anti-Rejection strategy may spare kidney function after liver transplant
- Artificial intelligence may help decide who gets a liver first
- Bringing the hospital home: a new model for End-Stage liver care